Polypharmacy as maintenance treatment in bipolar illness: A systematic review.

Authors:
Amerio A; Russo D; Miletto N; Aguglia A; Costanza A and 8 more

Journal:
Acta Psychiatr Scand

Publication Year: 2021

DOI:
10.1111/acps.13312

PMCID:
PMC8453557

PMID:
33960396

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Psychiatr Scand

Abbreviation: Acta Psychiatr Scand

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychiatry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Strawbridge R; Kurana S; Kerr-Gaffney J and 4 more (2022) - Transparency Score: 3/6
Autism and self-harm: A population-based and discordant sibling study of young individuals.
Stark I; Rai D; Lundberg M and 4 more (2022) - Transparency Score: 2/6
Characteristics and predictors of off-label use of antipsychotics in general population sample.
Pirhonen E; Haapea M; Rautio N and 7 more (2022) - Transparency Score: 3/6
Childhood symptoms of attention-deficit/hyperactivity disorder and borderline personality disorder.
Tiger A; Ohlis A; Bjureberg J and 6 more (2022) - Transparency Score: 3/6
Childhood temperamental, emotional, and behavioral characteristics associated with mood and anxiety…
Bakken NR; Hannigan LJ; Shadrin A and 6 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS Dr. Amerio, Dr. Russo, Dr. Miletto, Dr. Aguglia, Dr. Costanza, Dr. Benatti, Prof. Odone, Dr. Barroilhet, Prof. Brakoulias, Prof. Dell’Osso, Prof. Serafini, and Prof. Amore report no conflicts of interest. Prof. Ghaemi is employed by Novartis Institutes for Biomedical Research and holds equity in Novartis."

Evidence found in paper:

"Funding Information"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025